Insulin Delivery Devices

Author:

Stewart Kristine M.1,Wilson Mary F.2,Rider Joan M.3

Affiliation:

1. 2002 Barritt St., Lansing, MI 48912;

2. St.Mary's Mercy Medical Center, Center for Diabetes and Endocrinology, 300 Lafayette SE, Suite, Grand Rapids, MI 49503.

3. Ferris State University-College of Pharmacy, Medical Education Research Center, 1000 Monroe NE, Office 502, Grand Rapids, MI 49503.

Abstract

More than 6million Americans require daily injections of insulin. Insulin therapy, using the vial and syringe method, can be complicated and time consuming. Insulin pens were introduced in the United States in 1987 and have simplified insulin administration for many patients. Continuous Subcutaneous Insulin Infusion (insulin pumps or CSII) is being utilized to achieve and maintain tight glycemic control for personswith Diabetes Mellitus (DM). CSII therapy has existed since the 1960s. These insulin delivery devices provide improvements in flexibility, convenience, and freedom for patients-with diabetes. These devices may also help promote dosing accuracy and often improve compliance. CSII uses only rapid acting insulin, which has more reliable and predictable absorption. Gone are the days of sliding scales and feeding times to match the insulin delivery systems. This article focuses on insulin pen therapy and other alternative methods of delivering insulin including insulin pump therapy.

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Evaluation of Patient Satisfaction After Using Prefilled Insulin Pen in Real Life in Lithuania;Journal of Diabetes Science and Technology;2015-03-20

2. Emerging diabetes therapies and technologies;Diabetes Research and Clinical Practice;2012-07

3. Humalog®KwikPen™: an insulin-injecting pen designed for ease of use;Expert Review of Medical Devices;2010-11

4. Insulin Use;Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome;2010-10-25

5. A Review of 25 Yearsʼ Experience with the NovoPen® Family of Insulin Pens in the Management of Diabetes Mellitus;Clinical Drug Investigation;2010-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3